Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Lilly sues companies for patent infringement

Lilly sues companies for patent infringement

4th December 2008

Lilly has said it has filed cases against Lupin Laboratories and Aurobindo Pharma.

The lawsuits are based on allegations the two companies have infringed its patent for the anti-depressant drug Cymbalta.

In the petition filed, Lilly goes on to say Lupin Laboratories breached intellectual property rights for the product, with Aurobindo Pharma accused of encroaching the license.

The patent of Cymbalta is set to expire in 2013 and the company says the drug has annual global sales of around $2 billion (1.37 billion pounds).

Last month, Lilly announced its partnership with a Chi-Med subsidiary to undertake drug discovery and development.

The agreement is set to see the company and Shanghai-based drug research and development organisation Hutchison MediPharma studying oncology-related pharmaceuticals.

Previous to the deal, Lilly also completed the acquisition of all outstanding shares of ImClone Systems.

Purchased at a price of $70 per share in cash, approximately 85.4 million shares were validly tendered and not withdrawn – accounting for 95.5 per cent of the company.

Founded in 1876, Lilly is based in Indianapolis, US and employs approximately 40,217 people around the world – of which 7,946 are engaged in research and development.

The company has manufacturing plants in 13 countries, with products marketed in 143.

We currently have 7 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.